NDC 81033-104 – Atovaquone

Atovaquone 750 mg/5mL · Suspension · Oral

Human Prescription Drug

Product NDC81033-104

Product details

Brand name
Atovaquone
Generic name
Atovaquone
Labeler
Kesin Pharma
Dosage form
Suspension
Route
Oral
Marketing category
ANDA · ANDA212918
Marketed since
June 17, 2024
Listing expires
December 31, 2026
Pharmacologic class
Antimalarial; Antiprotozoal

Active ingredients

Uses, dosage, side effects and warnings for Atovaquone →

Package NDC codes (3)

Package NDCDescriptionSince
81033-104-2220 CUP, UNIT-DOSE in 1 CARTON (81033-104-22) / 5 mL in 1 CUP, UNIT-DOSE (81033-104-05)Sep 15, 2025
81033-104-4242 CUP, UNIT-DOSE in 1 CARTON (81033-104-42) / 5 mL in 1 CUP, UNIT-DOSE (81033-104-05)Jun 17, 2024
81033-104-5050 CUP, UNIT-DOSE in 1 CARTON (81033-104-50) / 5 mL in 1 CUP, UNIT-DOSE (81033-104-05)Jun 17, 2024

Other Atovaquone products